Deferiprone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Deferiprone.
| Product ID | 51672-4196_4028eb31-5ba4-4626-9f1c-32e913896561 | 
| NDC | 51672-4196 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Deferiprone | 
| Generic Name | Deferiprone | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2019-02-08 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA208800 | 
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. | 
| Substance Name | DEFERIPRONE | 
| Active Ingredient Strength | 500 mg/1 | 
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2019-02-08 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA208800 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-02-08 | 
| Ingredient | Strength | 
|---|---|
| DEFERIPRONE | 500 mg/1 | 
| SPL SET ID: | 5af1643d-4c6e-4668-ae9b-1046f0ad6d8a | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0054-0576 | Deferiprone | Deferiprone | 
| 0054-0711 | Deferiprone | Deferiprone | 
| 51672-4196 | Deferiprone | Deferiprone | 
| 10122-100 | FERRIPROX | deferiprone | 
| 10122-101 | FERRIPROX | deferiprone | 
| 10122-103 | FERRIPROX | DEFERIPRONE | 
| 10122-104 | FERRIPROX | deferiprone | 
| 52609-0006 | FERRIPROX | deferiprone | 
| 52609-0007 | FERRIPROX | deferiprone | 
| 52609-4502 | FERRIPROX | deferiprone | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() DEFERIPRONE  97303966  not registered Live/Pending  | 
        Beer, Kenneth  2022-03-09  |